Hawkinson Russ's Form 4/A amendment
AmendedARS Pharmaceuticals, Inc. (SPRY) · filed Feb 24, 2022
- Accession no.
- 0001209191-22-012878
- Filed
- Feb 24, 2022
- Trade date
- Dec 8, 2020
- Filing delay
- 443 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Dec 8, 2020
This filing lists 1 non-derivative transaction. Open-market purchases total $4.20K. It was filed 443 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hawkinson RussCIK 0001831807 | Officer (Sr. Vice President of Finance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2020 | Common Stock | PPurchaseAcquired | +200 | $21.00 | +$4,200 | 200 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The shares were purchased in the Issuer's initial public offering.
- F2
On December 8, 2020, the reporting person filed a Form 4 in which he inadvertently reported a purchase of 238 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person purchased 200 shares of the issuer's common stock.